(Q46105903)

19 December 2017

title

Advanced glycation end products in the development of ischemic and dilated cardiomyopathy in patients with diabetes mellitus type 2. (English)

1 reference

19 December 2017

main subject

dilated cardiomyopathy

1 reference

9

M Zembala

1 reference

19 December 2017

Michał Zakliczyński

2

M Zakliczyński

1 reference

19 December 2017

Dariusz Lange

7

D Lange

1 reference

19 December 2017

Marcin Maruszewski

8

M Maruszewski

1 reference

19 December 2017

D Konecka-Mrówka

3

D Konecka-Mrówka

1 reference

19 December 2017

Ewa Zembala-Nozynska

6

E Zembala-Nozyńska

1 reference

19 December 2017

J Mlynarczyk-Liszka

5

J Mlynarczyk-Liszka

1 reference

19 December 2017

author name string

J Nozyński

1

1 reference

19 December 2017

B Nikiel

4

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

19 December 2017

Transplantation Proceedings

published in

1 reference

19 December 2017

volume

41

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

99-104

1 reference

19 December 2017

Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Role of advanced glycation end products in diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Risk factors for wound infection after off-pump coronary artery bypass grafting: should bilateral internal thoracic arteries be harvested in patients with diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Sternal wound infections following cardiac surgery: risk factor analysis and interdisciplinary treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Twenty-year survivors of heart transplantation at Stanford University

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Morphological characteristics of coronary atherosclerosis in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

RAGE and its ligands: a lasting memory in diabetic complications?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Clinical and prognostic value of advanced glycation end-products in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis? An endomyocardial biopsy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Myocardial apoptotic index based on in situ DNA nick end-labeling of endomyocardial biopsies does not predict prognosis of dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

High-fat diet enhances visceral advanced glycation end products, nuclear O-Glc-Nac modification, p38 mitogen-activated protein kinase activation and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Overexpression of Gsalpha compensates for myocyte loss in diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Localization of advanced glycation endproducts in the kidney of experimental diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.09.065

10.1016/J.TRANSPROCEED.2008.09.065

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017